Celebrex Label Update Has CV Profile Similar To NSAIDs, No New GI Safety

The updated labeling for Pharmacia/Pfizer's COX-2 inhibitor Celebrex draws an unequivocal distinction between it and Merck's COX-2 Vioxx

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet